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Abstract
Background: Because of the low sensitivity of conventional rapid diagnostic tests (RDTs) for malaria infections,
the actual prevalence of the diseases, especially those caused by non-Plasmodium falciparum (non-Pf) species,
in asymptomatic populations remain less defined in countries lacking in well-equipped facilities for accurate
diagnoses. Our direct blood dry LAMP system (CZC-LAMP) was applied to the diagnosis of malaria as simple,
rapid and highly sensitive method as an alternative for conventional RDTs in malaria endemic areas where
laboratory resources are limited.
Results: LAMP primer sets for mitochondria DNAs of Plasmodium falciparum (Pf) and human-infective species
other than Pf (non-Pf; P. vivax, P. ovale, P. malariae) were designed and tested by using human blood DNA
samples from 74 residents from a malaria endemic area in eastern Zambia. These malaria dry-LAMPs were optimized for
field or point-of-care operations, and evaluated in the field at a malaria endemic area in Zambia with 96 human blood
samples. To determine the sensitivities and specificities, results obtained by the on-site LAMP diagnosis were compared
with those by the nested PCR and nucleotide sequencing of its product. The dry LAMPs showed the sensitivities of
89.7% for Pf and 85.7% for non-Pf, and the specificities of 97.2% for Pf and 100% for non-Pf, with purified blood DNA
samples. The direct blood LAMP diagnostic methods, in which 1 μl of anticoagulated blood were used as the template,
showed the sensitivities of 98.1% for Pf, 92.1% for non-Pf, and the specificities of 98.1% for Pf, 100% for non-Pf. The
prevalences of P. falciparum, P. malariae and P. ovale in the surveyed area were 52.4, 25.3 and 10.6%, respectively,
indicating high prevalence of asymptomatic carriers in endemic areas in Zambia.
Conclusions: We have developed new field-applicable malaria diagnostic tests. The malaria CZC-LAMPs showed high
sensitivity and specificity to both P. falciparum and non-P. falciparum. These malaria CZC-LAMPs provide new means for
rapid, sensitive and reliable point-of-care diagnosis for low-density malaria infections, and are expected to help update
current knowledge of malaria epidemiology, and can contribute to the elimination of malaria from endemic areas.
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Background
Malaria is one of the commonest and most important
infectious diseases in tropical and sub-tropical countries.
In sub-Saharan Africa, Plasmodium falciparum is
thought to be the most prevalent among Plasmodium
species. Although P. falciparum has been well investi-
gated epidemiologically, non-P. falciparum malaria in-
fections have been rather neglected because of their less
severe clinical symptoms and difficulties of diagnosis.
Therefore, the endemicity of P. vivax has only been
reported recently [1], and actual distributions of P.
malariae and P. ovale are still unknown [2].
Recently it turned out to be clear that the duration of
infections with both P. falciparum and P. malariae is
quite longer than previously estimated, despite the fact
that these two species do not turn into hypnozoite, the
dormant liver stage usually observed in P. vivax and P.
ovale infections [3]. During chronic infection phase of
malaria, parasitemia always are kept at low density. In
high endemic area of malaria, asymptomatic P. falcip-
arum-infected individuals with low-density parasitemia
that is undetectable by the conventional rapid diagnostic
tests (RDT) including light microscopy test or immuno-
chromatographic test (ICT), are very common. In view
of the fact that even the density of parasitemia is very
low, it is possible to transmit malaria gametocytes into
Anopheles mosquitos, part of which become infective to
human. Consequently, asymptomatic P. falciparum or P.
malariae carrier could be the reservoir for malaria infec-
tion. Therefore, highly sensitive diagnostic tools which
are able to detect low-density parasitemia are essential
for elimination of malaria.
Molecular diagnostic tests are highly sensitive methods
to detect malaria infection even at very low parasitemia
levels. For instance, polymerase chain reaction (PCR)
amplification is one of the most sensitive and reliable
methods to detect malaria parasite DNA. Compared to
RDTs, PCR requires an expensive equipment such as a
thermal-cycler, and well-equipped and clean laboratory
conditions. Nucleic acid extraction tools from blood
samples are sometime required for PCR. Therefore, PCR
is not suitable for the use in resource-poor settings
where malaria is endemic. Loop-mediated isothermal
amplification (LAMP) is an alternative molecular
method which requires neither expensive machines nor
clean laboratory [4]. Although LAMP is more user-
friendly, it still needs burdensome blood sample
preparation.
Previously, we have developed a direct blood dry
LAMP diagnostic system, named CZC-LAMP, for detec-
tion of human African trypanosomiasis (HAT) [5]. As is
the case with conventional RDT, a drop of blood
obtained by pricking a finger or an earlobe is sufficient
and able to be used directly for the CZC-LAMP. In this
study, we applied this system to develop a new easy-to-
use RDT that is able to differentiate P. falciparum and




LAMP primer sets were used to detect a part of
mitochondrial DNA (mtDNA) of human-infective
Plasmodium species. The LAMP primer sets consist-
ing of F3 (forward outer primer), B3 (backward outer
primer), FIP (forward inner primer), BIP (backward
inner primer), LF (loop forward primer), and LB (loop
backward primer) were designed as previously
described by Notomi et al. [4] and are listed in
Table 1. The LAMP primer set targeting mtDNA for
non-P. falciparum species (P. malariae, P. ovale
curtisi, P. ovale wallikeri and P. vivax) were designed
in this study using online PCR primer design tool
Primer3 [6, 7]. The sequences of the same target
region are also conserved in P. knowlesi and P. cyno-
molgi (Fig. 1). We also modified P. falciparum
mtDNA detection primer sets reported in a previous
literature [8]. After the primer sets were evaluated by
real-time LAMP using the Rotor-Gene 3000 thermo-
cycler (Corbett Research, Sydney, Australia) to select
the best candidate primer sets by monitoring the re-
action speed, cross-reactivity, primer multimer forma-
tion and optimal amplification time, the optimal
temperature of LAMP reaction for the primer sets
was determined.
LAMP reaction
The preparation of dry LAMP (CZC-LAMP) reagent
was previously described [5]. Briefly, 3.0 μmol of trehal-
ose, 35 nmol each of dNTPs mix and 8 U of Bst2.0 WS
DNA polymerase were mixed and dried on the lid of a
0.2 ml microtube. Colori-Fluorometric Indicator (CFI;
3 nmol hydroxyl-naphtol blue with 3.5 nl GelGreen™
(10,000× Sol), 3.2 pmol of FIP and BIP, 0.4 pmol of F3
and B3, and 1.6 pmol of LF and LB primers were mixed
and dried to prepare a dry LAMP tube.
When genomic DNA purified from the blood from
malaria infected patients were used as a reaction tem-
plate, 1 μl of extracted DNA solution plus 24 μl of 1×
LAMP reaction buffer (20 mM Tris-HCl [pH 8.8],
10 mM KCl, and 7 mM MgSO4 and 0.1% TritonX-100
in DDW) were added to make a 25 μl reaction mix,
which was added to the LAMP reaction tube. The tubes
were turned upside down several times, so that the dried
reagents were completely reconstituted. For the direct
blood LAMP method, 1 μl of anticoagulated patient
blood was mixed with 24 μl of 1× LAMP buffer, which
had been placed in a dry LAMP tube. After the reaction
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tubes were incubated at 60 °C for 40 min for P. falcip-
arum and 60 min for non-P. falciparum detection, amp-
lified DNA products were visualized using GelGreen™
contained in the CFI using battery-driven hand-made
LED illuminator that was designed for suitable field use
[5]. Positive samples exhibited a bright fluorescent green
colour under a transilluminator, and two independent
observers recorded the result.
Plasmodium nested PCR
Nested PCR for P. falciparum and non-P. falciparum
SSUrRNA was performed according to the published
methods [9]. Nested PCR detection of non-P. falciparum
infection was double-checked by mtDNA nested PCR
primers newly designed in this study by using Primer 3
online program (Table 1). After 25 cycles of 1st PCR
(denaturing at 98 °C for 10 s, annealing at 64 °C for 30 s
and extension at 72 °C for 50 s), 0.5 μl of 1st PCR prod-
uct was used for 2nd PCR template which was subjected
to 25 cycles of the same program as 1st PCR. All PCR
reactions were carried out with ExTaq Hot Start Version
(Takara-Bio, Shiga, Japan) in a volume of 20 μl. Ampli-
cons of the SSUrRNA and mtDNA nested PCR were
sequenced by ABI 3130 capillary sequencer to identify
Fig. 1 LAMP primers designed for Pf and non-Pf malaria detection. Primer sets for Pf and non-Pf malaria are indicated in P. falciparum (Pf), P. vivax
(Pv), P. ovale curtisi (Poc), P. ovale wallikeri (Pow), P. malariae (Pm), P. knowlesi and P. cynomolgi
Table 1 LAMP and nested PCR primer sequences for Pf and non-Pf used in this study
Primer set Primer Target species Sequence (5'-3')
Non-Pf CZC-LAMP primer set (7 primers) Non-Pf.Mt-FIP Pv, Poc, Pow, Pm AGGCTGCGATGAGACGACGCCGGGGATAACAGGTTATAGT
Non-Pf.Mt-BIP Pv, Poc, Pow, Pm AGCGTGTATTGTTGCCTTGTACTTAACGCCTGGAGTTCTTTATCTT
Non-Pf.Mt-LF Pv, Poc, Pow, Pm TGGAGGTGCCAATAGTATATAAAGAT
Non-Pf.Mt-LB Pv, Poc, Pow, Pm TGTACACACCGCTCGTCAC
Pov.Mt-F3 Pv, Poc, Pow GGTGATTTTGTGTGCCGTT
Pm.Mt-F3 Pm ACGGTTATTTTGTGTACCGTT
Non-Pf.Mt-B3 Pv, Poc, Pow, Pm CGGCTGTTTCCATCTCAACT






Non-Pf nested PCR primers PnfMt-Fout Pv, Poc, Pow, Pm TGCTGTCATACATGATGCACTT
PnfMt-Rout Pv, Poc, Pow, Pm ATGTAGTTTCCTCACAGCTTTATTCA
PnfMt-Fin Pv, Poc, Pow, Pm TGCTGTCATACATGATGCACTT
PnfMt-Rin Pv, Poc, Pow, Pm ATAACATTTTTTAGTCCCATGCTAGTA
aThe published LAMP primer sequence (PfMt869) [8] was used
Abbreviations: Pv P. vivax, Pow P. ovale wallikeri, Poc P. ovale curtisi, Pm P. malariae, Pf P. falciparum
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the species of non-P. falciparum. In case of detection of
mixed wave patterns in the DNA sequencing, the ampli-
con was cloned into pGEM-T Easy vector (Promega,
USA), and then several clones were sequenced. Before
the final confirmation of results, all negative samples of
first screening were re-examined by nested PCR.
Immunochromatographic test (ICT) for malaria
As a malaria conventional RDT that immunologically
detects and differentiate P. falciparum and non-P.
falciparum species, Hexagon Malaria Combi™ test
(Human Gesellschaft für Biochemica und Diagnostica,
Wiesbaden, Germany) was used in accordance with
the manufacturers’ instructions. The results were read
at 15 min after the first diluent drop had been ap-
plied into the sample window. Even a faint color band
was read as positive. Two independent observers con-
firm and record the result.
Field studies
Malaria diagnoses, ICT and malaria CZC-LAMP were
performed for 35 voluntary participated residents at
Chinshimbwe in the eastern Zambia, (14°3'2.12"S, 30°
58'48.15"E) on August 15th and 61 residents at
Shikabeta (14°57'12.41"S, 29°49'54.54"E) in the east central
Zambia, on August 20th 2013 (Additional file 1: Figure S1).
After a brief interview and signing an informed consent
form, 2 ml of venous blood were collected in a heparin-
containing BD Vacutainer tubes (Becton, Dickinson and
Company, USA). Hexagon malaria combi test, and CZC-
LAMP tests were performed within 10 min after blood
collection as described above. Blood samples were kept at
4 °C for 3 to 4 days during transportation to Lusaka, and
frozen at -80 °C in the laboratory at the University of
Zambia, Lusaka. About 200 μl of each blood sample was
used for DNA extraction by using QuickGene DNA whole
blood kit (FujiFilm, JAPAN). These DNA samples were
used for the nested PCR analysis.
Human blood samples collected at Mwanya in the
eastern Zambia (12°72'82.93"S, 32°24'88.54"E) on
October 24th, 2012 were also used to establish our
LAMP system.
Data management and statistical analysis
LAMP, ICT and PCR data were entered in Microsoft
Office Excel 2011. Nested-PCR results were used as
reference tests. Sensitivity was estimated as the number
of both LAMP and nested-PCR positives divided by the
number of nested-PCR positives. Specificity was esti-
mated as the number of both LAMP and nested-PCR
positives divided by the total number of LAMP positives.
Binomial exact 95% CIs were calculated for sensitivities
and specificities.
Results
Malaria nested PCR diagnosis for extracted blood DNA
Prior to develop malaria CZC-LAMP, extracted DNAs
from human blood samples collected from Mwanya in
eastern Zambia were analyzed by malaria nested PCR
(Table 2). Based on this result on 74 asymptomatic
Mwanya individuals, 42 were parasite DNA-positive
while 32 were negative. Among the positive samples, 21
were P. falciparum (Pf )-single infection, 3 were non-P.
falciparum (non-Pf ) single infection and 18 were mixed
infection with Pf /non-Pf. The details of non-Pf infec-
tions were single infection with P. malariae (Pm; 13
cases), P. ovale curtisi (Poc; 4), P. ovale wallikeri (Pow;
2), and other two cases were Pm/Poc mixed infections.
When the nested PCR results were used as reference,
the sensitivities of ICT were 48.7% (95% CI: 32.5–64.9)
for Pf and 14.3% (95% CI: 0–30.2) for non-Pf, the speci-
ficities were 95.0% (95% CI: 84.8–100) for Pf and 60.0%
(95% CI: 0–100) for non-Pf. The integrated sensitivity
and specificity of malaria ICT for Pf and non-Pf were
47.6 and 95.2%, respectively.
Development and evaluation of Pf and non-Pf detecting
LAMP primers using extracted blood DNA samples
To differentiate Pf from non-Pf, we designed several
LAMP primer sets so that mtDNAs of non-Pf species
can be detected universally without cross-reaction with
Pf. The extracted DNA samples of non-Pf single infec-
tion (ID #11 and 50 in Table 2) were used as template
for screening and selection. At the same time, those of
Pf single infection (ID #1 and 7 in Table 2) were used as
negative control to exclude Pf cross-reactive primers.
After the real time LAMP and melting curve analyses of
those DNA samples, the best primer set was selected
(Fig. 1). In the same way, Pf-specific LAMP primer set
was also selected. Because there is a published LAMP
primer set which detects Pf mtDNA specifically [8], we
also tested these six primers as candidates, while half of
them were replaced by newly designed primers to im-
prove sensitivity and specificity (Table 1).
The performances of non-Pf and Pf primer sets were
evaluated by using extracted DNA samples described
above (Table 2). Of the 74 samples, non-Pf LAMP
specifically detected 18 non-Pf PCR positive samples
without cross-reaction to Pf or nonspecific reaction to
malaria-free DNA samples. Although non-Pf LAMP
detected Pm and Po equally, these two species could not
be detected in three of non-Pf PCR-positive samples (ID
#9, 18 and 34). On the other hand, Pf LAMP reacted to
35 Pf PCR-positive samples and to one (ID #80) malaria
PCR-negative one, but missed four Pf PCR-positive sam-
ples (ID #10, 41, 42 and 54). The existing LAMP primer
set (PfMt869) [8] was also used for comparison. LAMP
with PfMt869 primer sets detected 33 Pf PCR positive
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samples and also detected the same malaria PCR-
negative sample that was positive by CZC-Pf LAMP (ID
#80 in Table 2). If the nested PCR results were used as a
standard, sensitivities were 85.7% for non-Pf LAMP and
89.7% for Pf LAMP; specificities were 100% for non-Pf
LAMP and 97.2% for Pf LAMP. Nested PCR-positive
and ICT-negative samples were supposed to be infec-
tions with very low parasitemia. The sensitivities of three
LAMP primer sets for those of low density samples were
83.3% (non-Pf ), 80.0% (Pf ) and 70.0% (PfMt869)
(Table 3). All nested PCR-positive and ICT-positive
which were supposed to be high parasitemic samples
were detected by non-Pf, Pf and PfMt869 LAMP primer
sets with 100% of sensitivity.
Evaluation of malaria CZC-LAMP in field surveillance at
the malaria endemic areas in Zambia
Next, we evaluated the performance of Pf and non-Pf
malaria CZC-LAMP in the malaria endemic areas where
we used 1 μl of anticoagulated unprocessed blood for
each kit instead of using purified DNA or other proc-
essed blood materials. For the diagnosis, ICT was also
performed at the same time. Representative visual
appearance of test tubes after Pf CZC-LAMP reaction is
shown in Fig. 2, and the results are summarized in
Tables 4 and 5.
Of the 35 blood samples in Chinshimbwe, 8 were posi-
tive for non-Pf CZC-LAMP and 22 were positive for Pf
CZC-LAMP, while ICT detected 2 non-Pf and 14 Pf. At
this sampling site, nested PCR results which had been
done later at the laboratory in Lusaka were exactly
matched to those obtained by both non-Pf and Pf mal-
aria CZC-LAMPs, resulting in 100% of the sensitivities
and specificities. In case of ICT, we observed false posi-
tive cases in 2 Pf and 1 non-Pf samples. The sensitivities
of ICT were 13% and 55%, and the specificities were
50% and 80% for non-Pf and Pf, respectively.
Of the 61 blood samples collected from Shikabeta
area, nested PCR detected 30 non-Pf-positive cases (21
Pm, 5 Poc, 2 Pow, 1 P. vivax [Pv] single infections and 1
Pm/Poc mixed infection). Non-Pf CZC-LAMP detected
27 of the 30 PCR-positive cases, 3 false negatives but no
false positive samples. In addition, 30 Pf-positive samples
Table 2 Results of malaria diagnostic tests for archived












1 – – – + + +
7 – – – + + +
9 F – Pow + + +
10 – – – – – +
11 – + Pow – – –
13 – – – + + +
14 F – – + + +
15 F – – + + +
17 F + Pm + + +
18 – – Pm + Poc + + +
19 – – – + + +
20 – – – + + +
23 – – – + + +
27 F, NF + Poc + + +
29 F – – + + +
30 F + Poc + + +
32 – + Pm + + +
34 – – Pm + Poc + + +
40 F, NF – – + + +
41 – – – – – +
42 – + Pm – – +
43 – – – + + +
44 – + Poc – – –
45 F – – + + +
50 NF + Pm – – –
52 F + Pm + + +
54 – – – – – +
55 F + Pm + + +
58 F + Pm + + +
61 F, NF + Pm + + +
63 F + Poc + + +
64 F + Pm + + +
65 F – – + + +
66 – + Pm + + +
71 – – – – + +
73 F, NF – – – – –
75 – – – + + +
80 – – – + + –
85 – + Pm – + +
87 F + Pm + + +
Table 2 Results of malaria diagnostic tests for archived
extracted DNA of blood samples collected from Mwanya,
eastern Zambia (Continued)
89 – – – + + +
91 F – – + + +
95 – + Pm + + +
103 F – – + + +
Abbreviations: F P. falciparum positive in ICT, NF non-P. falciparum positive in
ICT, Pow P. ovale wallikeri, Poc P. ovale curtisi, Pm P. malariae
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were detected by nested PCR. CZC-LAMP detected 29
nested PCR-positive samples and 1 false positive sample
when the Pf nested PCR results were used as a reference.
The sensitivities and specificities of non-Pf/Pf CZC-
LAMP in Shikabeta were 90%/96.7% and 100%/96.7%,
respectively. On the other hand, the sensitivities and
specificities of non-Pf/Pf ICT were 40%/67% and 100%/
87%, respectively.
Overall sensitivities and specificities of non-Pf CZC-
LAMP obtained during this study were 92.1 and 100%;
and Pf CZC-LAMP were 98.1 and 98.1%, respectively
(Table 6). On the other hand, the sensitivities and speci-
ficities of ICT were 34.2% (95% CI: 18.6–49.8) and
92.9% (95% CI: 78.0–100) for non-Pf, 61.5% (95% CI:
47.9–75.1) and 86.5% (95% CI: 75.1–97.9) for Pf, respect-
ively. In addition, although non-Pf CZC-LAMP reacted
to four non-Pf malaria species (Pm, Poc, Pow and Pv),
cross-reaction between non-Pf and Pf was not observed
at all. As is the case with purified DNA samples, non-Pf
and also Pf CZC-LAMPs detected all high-parasitemic
samples which were both nested PCR- and ICT-positive.
In the case of low density conditions, the sensitivities of
non-Pf and Pf CZC-LAMP were 88.0 and 95.0%,
respectively (Table 6).
Discussion
In this study, we conducted field surveillance studies of
malaria in the remote rural parts of the eastern Zambia
using a field-applicable molecular diagnosis system,
CZC-LAMP. We demonstrated that Pf and non-Pf
CZC-LAMPs were substantially superior in terms of
sensitivity and specificity to the conventional ICT. Not
only did both Pf and non-Pf CZC-LAMP perfectly de-
tected parasite DNA from moderate-density parasitemia
samples which were both ICT- and nested PCR-positive,
but non-Pf CZC-LAMP improved the sensitivity of non-
Pf malaria diagnosis (34.2% by ICT to 92.1%) without
sacrificing specificity. In addition, Pf CZC-LAMP exhib-
ited better sensitivity than existing Pf LAMP and was
thus almost as sensitive as nested PCR when blood
Table 3 Diagnostic accuracy of malaria LAMPs for archived extracted DNA of blood samples collected from Mwanya, eastern
Zambia
Pf CZC-LAMP PfMt869-LAMPa non-Pf CZC-LAMP
% (95% CI) % (95% CI) % (95% CI)
Total Sensitivity 89.7 (79.9–99.5) 84.6 (72.9–96.3) 85.7 (69.9–100)
Specificity 97.2 (91.7–100) 97.1 (91.2–100) 100
ICT positive Sensitivity 100 100 100
Specificity 100 100 100
ICT negative Sensitivity 80.0 (61.3–98.7) 70.0 (48.6–91.4) 83.3 (64.8–100)
Specificity 94.1 (82.0–100) 93.3 (79.5–100) 100
aThe published LAMP primer sequence (PfMt869) [8] was used
Fig. 2 Visual determination of positive and negative samples. Examples of malaria CZC-LAMP tubes after the reaction. It is not possible to
determine positive or negative under natural light due to the interference by hemoglobin (lower). However, positive samples emit green
fluorescence under 505 nm blue-green light (upper)
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samples were directly subjected to the analysis without
any DNA extraction or purification steps.
Our initial aim was to develop a field-applicable sim-
plified molecular diagnosis method, but we have also
achieved increased sensitivity with both Pf and non-Pf
CZC-LAMP for low-parasitemia samples when the test
samples switched from purified DNA to anticoagulated
otherwise unprocessed fresh blood (83.3 to 88% for non-
Pf and 80 to 95% for Pf ). Therefore, the LAMP method
in which unprocessed blood is used exhibits a superior
sensitivity to that of the existing LAMP method which
employs extracted DNA from the blood. This
minimization of sample preparation process has advan-
tage for the point-of-care test under resource poor
settings.
ICT is most commonly used Malaria RDTs showing
high sensitivities and specificities, especially when para-
site burden is high in sick patient. It has been demon-
strated that Hexagon rapid diagnostic test showed 100%
Table 4 Results of malaria CZC-LAMP for blood samples col-









C01 – + Pm + +
C04 F + Pm + +
C05 – – – + +
C06 F – – + +
C07 – – – + +
C09 – – – + +
C10 F, NF – – + +
C12 F – – + +
C14 – – – + +
C15 F + Poc + +
C16 – – – + +
C17 F – – + +
C19 F – – + +
C22 F + Pm + +
C23 F – – + +
C24 – + Pm + +
C25 – – – + +
C26 – + Pm + +
C27 F – – + +
C30 F, NF + Pm + +
C31 F – – – –
C32 F – – + +
C33 F – – – –
C35 – + Pow + +
Abbreviations: F P. falciparum positive in ICT, NF non-P. falciparum positive in
ICT, Pow P. ovale wallikeri, Poc P. ovale curtisi, Pm P. malaria
Table 5 Results of malaria CZC-LAMP for blood samples collected









S03 – – – + +
S06 – – – + +
S09 – + Poc – –
S10 F, NF + Pm + +
S11 F, NF + Pm + +
S12 F + Pm + +
S14 F + Pm + +
S15 F + Pm + Poc + +
S18 – – – + +
S19 F + Pm – –
S20 – + Pm – –
S22 – + Poc + +
S23 F, NF + Pm + +
S24 – – – + +
S25 F + Pm + +
S26 F – – – –
S27 – + Poc – –
S29 – + Pm + +
S31 F, NF + Pv + +
S32 F + Pm + +
S33 – + Pm – –
S35 F, NF + Pm + +
S36 F, NF + Pm + +
S37 F, NF + Pm + +
S38 F – – + +
S39 – + Pow – –
S40 – – – + +
S41 F – – – –
S42 F, NF + Pm + +
S43 F + Pow + +
S44 NF + Pm – +
S47 – – – + +
S48 F + Pm + +
S50 – – Poc – –
S51 F – Pm + +
S52 F, NF + Poc + +
S54 F, NF + Pm + +
S56 – – – + –
S57 F – – – –
S59 – – Pm + +
S61 F, NF + Pm + +
Abbreviations: F P. falciparum positive in ICT, NF non-P. falciparum positive in
ICT, Pow P. ovale wallikeri, Poc P. ovale curtisi, Pm P. malariae
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sensitivity both for Pf and non-Pf, if > 5,000 parasite/μl
blood were used. But this sensitivity was dramatically
dropped when low-density patient blood showing < 500
parasite/μl were used, showing 50 and 0% sensitivity for
Pf and non-Pf [10]. As such, although ICT is useful in
terms of simple operation and sensitivity for high para-
sitemia patient, more sensitive and specific alternative
diagnostics must be developed for controlling malaria in
endemic areas.
For the purpose of malaria DNA detection, commer-
cial malaria LAMP kits to detect Pf and pan-
plasmodium species (Loopamp™ MALARIA Pan/Pf
Detection Kit, Eiken Chemical Company, Japan) are
already available. Although these kits also demonstrated
excellent performance in malaria detection, even at low-
density parasitemia, comparable to nested PCR in min-
imally equipped laboratories [11–13], our Pf/non-Pf
CZC-LAMP have advantages over these kits in the fol-
lowing points. First, the CZC-LAMPs use a minute
amount of blood from the patient which can be intro-
duced into the reaction without any process. CZC-
LAMP require neither DNA extraction by PURE method
nor blood boiling and spin down steps, and are as con-
venient as conventional ICT using less than 5 μl of
blood collected. In addition, direct blood method may
contribute to sensitization of LAMP reaction as men-
tioned above. Secondly, CZC-LAMPs are important to
determine whether non-Pf malaria species are in a
mixed infection with Pf or not. This suggests that rapid
and accurate point-of-care diagnoses of monolithic Pf or
non-Pf as well as Pf/non-Pf mixed infection, are pos-
sible, facilitating for the immediate and effective medica-
tion of the affected patients. The other advantages of
CZC-LAMP over existing LAMP were already described
in our previous report [5].
Recent molecular epidemiological studies of malaria
detection and species discrimination by nested PCR in
sub-Saharan Africa have shown that there exist mixed
infections of low-density non-Pf species other than Pv
with Pf much more than previously considered [14–16].
In Zambia, the situation of mixed infections with low-
density Pf and non-Pf had largely remained unexplored
until the recent study using stored samples from the
children under 6 years old and nested PCR was pub-
lished [17]. In the present study, we report the detection
of many cases of mixed infections of low-density Pf and
non-Pf (mainly Pf + Pm and to a lesser extent Pf + Po),
and also a few non-Pf monolithic infections at sam-
pling points in the eastern Zambia (Additional file 2:
Table S1). Artemisinin used as first-line medicine in
several sub-Saharan African counties fails to elimin-
ate Pm, Po and also low-density Pf [18]. These find-
ings suggest that there is a need for continuous
monitoring of non-Pf infections and low-density Pf
prevalence for effective treatment to malaria species.
Our Pf and non-Pf CZC-LAMPs are expected to be
extremely useful in the diagnosis or surveillance
studies of malaria in sub-Saharan African countries.
CZC-LAMPs are also useful means to monitor and con-
firm the negative transmission in the area where malaria
elimination is almost achieved. Because malaria CZC-
LAMP is relatively cost-effective and easy for operation,
this can be applied for active and massive vector surveil-
lance. Therefore, application of our malaria CZC-LAMP
to mosquito lysate or extracted DNA is required in future
work.
In conclusion, these Pf and non-Pf CZC-LAMPs
showed higher sensitivity/specificity compared to con-
ventional ICT. As for the new RDT, CZC-LAMP will
provide new paradigm of malaria infection, low-
density chronic infection and transmission. Therefore,
these diagnosis tools will not only elucidate the full
picture of epidemiology of malaria but are also ex-
pected to contribute to reduction or elimination of
malaria infections from endemic areas in sub-Saharan
Africa.
Conclusions
Recent studies have indicated that low-density chronic
infection of malaria in asymptomatic patient, undetect-
able by conventional RDTs, is the next problem for mal-
aria infection control. Using human blood DNA samples
collected in malaria endemic area in Zambia, we have
developed malaria CZC-LAMP kits, new simple and
sensitive RDT, for falciparum malaria and non-
falciparum (four species) malaria, respectively. These kits
detected low-density, even falciparum/non-falciparum
mixed, infection with a high degree of accuracy in blood
samples collected in malaria endemic areas. This system
will elucidate the ecological geography of chronic
malaria infection especially for P. falciparum and P.
malariae, both of them do not have dormant liver stage,
and may contribute to complete elimination effort of
malaria.
Table 6 Diagnostic accuracy of malaria CZC-LAMP for blood
samples collected from Chinshimbwe and Shikabeta, eastern
Zambia
Pf CZC-LAMP Non-Pf CZC-LAMP
% (95% CI) % (95% CI)
Total Sensitivity 98.1 (94.3–100) 92.1 (83.3–100)
Specificity 98.1 (94.3–100) 100
ICT positive Sensitivity 100 100
Specificity 100 100
ICT negative Sensitivity 95.0 (84.8–100) 88.0 (74.6–100)
Specificity 95.0 (84.8–100) 100
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Additional files
Additional file 1: Figure S1. Samples collection sites in Zambia. Map
showing human blood sampling sites in Zambia. The red star indicates
the location of the sampling site. Red line: road; Blue line: landside
waters; Gray line; boundary line. The map was downloaded from the
International Steering Committee for Global Mapping. (TIFF 7390 kb)
Additional file 2: Table S1. Infection prevalence of Malaria species at
three sampling sites in Zambia. (DOCX 71 kb)
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